Aspira Women's Health DSO Ratio 2011-2026 | AWH

Annual DSO Ratio Aspira Women's Health

2025	2024	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.17 K	-	50.7	50.7	67.9	74.3	94	24	38	14.6	24.2	53.1	23.9	18.8

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.17 K	14.6	131

Quarterly DSO Ratio Aspira Women's Health

2025-Q3	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.24 K	41.8	-	54.6	56	63.4	-	66.4	58.5	55.1	-	50.9	49.6	52.1	-	59.6	51.4	55.4	-	63.7	106	66.9	-	65.6	73.8	97.2	-	92.7	101	69.7	-	26.8	20.8	30.2	-	40.3	35.4	32.7	-	24.1	14.8	12.2	-	47.2	47	80.8	-	103	105	70.9	-	39.2	38.9	34.5	-	28.2	29.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.24 K	12.2	82.6

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Trinity Biotech plc TRIB	87.2	$ 0.65	-1.84 %	$ 61.9 M	Irlanda
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Agilent Technologies A	63.8	$ 115.55	1.0 %	$ 35.1 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	94.7	$ 1.67	-2.34 %	$ 2.22 M	USA
Castle Biosciences CSTL	49.2	$ 24.46	3.25 %	$ 679 M	USA
CareDx, Inc CDNA	51.5	$ 21.23	5.83 %	$ 1.13 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	80.5	$ 84.33	1.82 %	$ 5.69 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	77.4	$ 16.31	1.75 %	$ 493 M	USA
Medpace Holdings MEDP	50.4	$ 410.54	4.35 %	$ 11.8 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 169.8	1.23 %	$ 8.42 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Guardant Health GH	46.1	$ 88.91	1.18 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	66.9	$ 1.98	-2.37 %	$ 8.76 M	USA
Illumina ILMN	61.3	$ 127.88	1.95 %	$ 20.3 B	USA
National Research Corporation NRC	29.4	$ 17.23	-0.12 %	$ 386 M	USA
Personalis PSNL	55.8	$ 6.1	3.39 %	$ 361 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Biomerica BMRA	57.7	$ 2.14	-0.47 %	$ 4.92 M	USA
ICON Public Limited Company ICLR	68.5	$ 102.17	-3.92 %	$ 8.43 B	Irlanda
Laboratory Corporation of America Holdings LH	52.9	$ 263.8	-0.43 %	$ 21.9 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Thermo Fisher Scientific TMO	70	$ 469.71	0.64 %	$ 177 B	USA
NeoGenomics NEO	77.7	$ 8.29	4.8 %	$ 1.06 B	USA
Neogen Corporation NEOG	66.6	$ 9.54	2.03 %	$ 2.07 B	USA
Twist Bioscience Corporation TWST	44.5	$ 60.94	3.55 %	$ 3.64 B	USA
Myriad Genetics MYGN	52.3	$ 4.78	-0.21 %	$ 443 M	USA
Natera NTRA	81.5	$ 203.75	1.3 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 196.27	-1.66 %	$ 21.8 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	79.8	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA
Waters Corporation WAT	306	$ 309.87	-0.43 %	$ 18.5 B	USA